Commonly prescribed medications such as statins, non-steroidal anti-inflammatory drugs and certain blood pressure drugs may significantly delay the onset of Parkinson’s disease.
The study, published in Journal of Neurology, reviewed medical records from over 1,200 Parkinson’s disease patients examined by movement specialists at Cedars Sinai Medical Center from October 2010 to December 2021 and found that those who had taken certain medications before their first symptom appeared developed the disease as much as 10 years later than those who had not.
The strongest independent predictors of delayed Parkinson’s onset were adrenergic blockers, statins and NSAIDs with each associated with the onset of occurring four to nearly six years later. In contrast, smoking and a family history of Parkinson’s were linked to earlier onset of the condition.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
